Focalin XR Adult ADHD Management Guidelines

Pre‑Treatment Assessment

Obtain baseline vital signs (blood pressure and pulse) before initiating Focalin XR and perform quarterly monitoring thereafter – recommended by the American Academy of Child and Adolescent Psychiatry (expert consensus) 1.
Conduct cardiovascular screening (history and physical examination) to exclude essential hypertension and cardiac arrhythmias prior to therapy – American Academy of Child and Adolescent Psychiatry guidance (expert consensus) 1.
Record baseline body weight to enable monitoring for potential appetite suppression during treatment – American Academy of Child and Adolescent Psychiatry recommendation (expert consensus) 1.

Do not apply immediate‑release methylphenidate dosing guidelines (e.g., 5 mg MPH or 2.5 mg dexmethylphenidate) to the extended‑release formulation; those lower doses pertain only to immediate‑release products. – American Academy of Child and Adolescent Psychiatry (expert consensus) [1][2].
Avoid escalating the dose beyond 40 mg/day; if the maximum studied dose is ineffective, consider switching to an alternative medication rather than further dose increase – American Academy of Child and Adolescent Psychiatry (expert consensus) 1.

Initial titration phase: contact the patient weekly (office visit or telephone) for the first 2–4 weeks while adjusting the dose. – American Academy of Child and Adolescent Psychiatry (expert consensus) 1.
Maintenance phase: schedule monthly appointments until symptoms are stable; thereafter adjust visit frequency based on clinical response and tolerability. – American Academy of Child and Adolescent Psychiatry (expert consensus) 1.
Ongoing vital‑sign monitoring: check blood pressure and pulse at least quarterly throughout treatment. – American Academy of Child and Adolescent Psychiatry (expert consensus) [1][3].